CFO Hahn buys 17,500 shares of GLYC at $0.25; stock down 92.8% from $349.00 high, revenue collapsed 86.7% YoY.
Brian M. Hahn, SVP Finance and CFO, purchased 17,500 shares at $0.25 on 2024-06-18, increasing his holdings by 32.9% to 70,643 shares post-transaction. This buy occurs at an extreme valuation nadir: the stock has fallen 92.8% from its 52-week high of $349.00, while the company's fundamentals have deteriorated sharply—annual revenue declined 86.7% and the latest quarter generated only $75,000 in revenue against a net loss of $-10.7M. The CFO's purchase of 17,500 shares at these depressed levels, despite the company's unprofitability and collapsing top line, warrants scrutiny regarding management's assessment of intrinsic value recovery versus market perception of the company's viability. The magnitude of the price decline (92.8%), combined with the severity of operational contraction (86.7% revenue drop), indicates a high-risk inflection point that investors should monitor closely.